Norrlands University Hospital
- Address
- lock Available on a paid plan
Hemic and Lymphatic Diseases
The obstetrics and gynecology department at Norrlands University Hospital is conducting innovative studies on blood‑related cancers, including acute lymphoblastic leukemia and diffuse large B‑cell lymphoma. Researchers aim to improve survival outcomes by testing newer chemotherapy combinations and refining treatment protocols.
- Evaluation of pola‑R‑mini‑CHP versus R‑mini‑CHOP in lymphoma patients
- Enhancing event‑free survival for infants with KMT2A‑rearranged acute lymphoblastic leukemia
With 15 investigators and a focused clinical trial portfolio, the site leverages its multidisciplinary expertise to advance therapies for hematologic malignancies across Europe.
Neoplasms
Clinical research at the Umeå campus also targets solid tumors such as endometrial cancer and HER2‑positive breast cancer. The trials emphasize biomarker‑driven approaches and novel targeted agents to increase cure rates and reduce treatment toxicity.
- Comparing biomarker‑based staging with conventional staging in early‑stage endometrial cancer
- Assessing neoadjuvant trastuzumab deruxtecan combined with dual HER2 blockade in non‑metastatic breast cancer
By integrating cutting‑edge diagnostics and therapeutic strategies, the hospital aims to set new standards for cancer care while fostering collaboration among clinicians and researchers.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 2 of 5 therapeutic areas and 15 of 68 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Top 40 of 68 compounds, ranked by number of trials.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 7 by active trials.
- 1Karolinska University Hospital3active
lock +6 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Karolinska University Hospital4trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 188 other sites in Sweden
Therapeutic Area Benchmark — Sweden
Select a therapeutic area to compare against other sites in Sweden.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Sweden
Market Share
Country: Sweden
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Norrlands University Hospital
lock Showing 1 of 15 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Randomized Trial of Trastuzumab Deruxtecan and Biology-Driven Selection of Neoadjuvant Treatment for HER2-positive Breast Cancer: ARIADNE | Karolinska University Hospital | Phase II | Recruiting | Jun 2023 | — |
IMP list
lock Showing 1 of 68 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Carboplatin | 4 | Unknown | 2020-03-11 | 2024-04-30 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.